SCB
EW icon

Saudi Central Bank’s Edwards Lifesciences EW Stock Holding History

Saudi Central Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Buy
+21,420
New +$1.77M 0.04% 229
2025
Q2 		– Sell
-232
Closed -$16.8K – 231
2025
Q1 		$16.8K Buy
+232
New +$16.6K 0.09% 216

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Saudi Central Bank's EW Position: Q1 2026 in Review

Saudi Central Bank opened a new position in Edwards Lifesciences (EW) in Q1 2026: 21,420 shares worth $1.72M. The stake represents 0.04% of the portfolio and ranks #229 among its holdings. This is a return to the name: Saudi Central Bank previously reported a position in EW as recently as Q1 2025.

Saudi Central Bank first reported a position in EW in Q1 2025 and has held it in 2 quarters since. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Saudi Central Bank held 21,420 shares of Edwards Lifesciences worth $1.72M as of Q1 2026.
  • Edwards Lifesciences was a new Saudi Central Bank position in Q1 2026.
  • Edwards Lifesciences made up 0.04% of Saudi Central Bank's portfolio in Q1 2026, its #229 holding.
  • Saudi Central Bank first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 2 quarters since.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Saudi Central Bank's 13F filing for Q1 2026, filed 15 May 2026.